1. Robbins, K.C., A study on the conversion of fibrinogen to fibrin. Am. J. Physiol., 1944. 142: p. 581-588.
2. Laki, K. and L. Lorand, On the Solubility of Fibrin Clots. Science, 1948. 108(2802): p. 280.
3. Sárváry, A., et al., Possible role of factor XIII subunit A in Fcγ and complement receptor-mediated phagocytosis. Cell Immunol, 2004. 228(2): p. 81-90.
4. Nikolajsen, C.L., et al., Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot. J Biol Chem, 2014. 289(10): p. 6526-34.
5. Nahrendorf, M., et al., Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res, 2007. 100(8): p. 1218-25.
6. Koseki-Kuno, S., et al., Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood, 2003. 102(13): p. 4410-2.
7. Asahina, T., et al., Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta, 2000. 21(4): p. 388-93.
8. Anwar, R. and K.J. Miloszewski, Factor XIII deficiency. Br J Haematol, 1999. 107(3): p. 468-84.
9. McDonagh, J., Structure and function of factor XIII, in Hemostasis and Thrombosis: Basic Principles and Clinical Practice, R.W. Colman, et al., Editors. 1994, Lippincott Williams & Wilkins: Philadelphia, PA. p. 301-311.
10. Board, P.G., et al., Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24—-p25. Cytogenet Cell Genet, 1988. 48(1): p. 25-7.
11. Yee, V.C., et al., Structure and function studies of factor XIIIa by x-ray crystallography. Semin Thromb Hemost, 1996. 22(5): p. 377-84.
12. Pedersen, L.C., et al., Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules. Protein Sci, 1994. 3(7): p. 1131-5.
13. Handrkova, H., V. Schroeder, and H.P. Kohler, The activation peptide of coagulation factor XIII is vital for its expression and stability. J Thromb Haemost, 2015. 13(8): p. 1449-58.
14. Komáromi, I., Z. Bagoly, and L. Muszbek, Factor XIII: novel structural and functional aspects. J Thromb Haemost, 2011. 9(1): p. 9-20.
15. Schroeder, V., et al., Free factor XIII activation peptide affects factor XIII function. Br J Haematol, 2015. 168(5): p. 757-9.
16. Ichinose, A., The physiology and biochemistry of factor XIII, in Haemostasis and Thrombosis, A.L. Bloom, et al., Editors. 1994, Churchill Livingstone. p. 531-546.
17. Board, P.G., M.S. Losowsky, and K.J. Miloszewski, Factor XIII: inherited and acquired deficiency. Blood Rev, 1993. 7(4): p. 229-42.
18. Mosesson, M.W., et al., Evidence that α2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation. J Thromb Haemost, 2008. 6(9): p. 1565-70.
19. Polgar, J., V. Hidasi, and L. Muszbek, Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem J, 1990. 267(2): p. 557-60.
20. Richardson, V.R., et al., Substrates of Factor XIII-A: roles in thrombosis and wound healing. Clin Sci (Lond), 2013. 124(3): p. 123-37.
21. Wolpl, A., et al., Coagulation factor XIII A and B subunits in bone marrow and liver transplantation. Transplantation, 1987. 43(1): p. 151-3.
22. Bottenus, R.E., A. Ichinose, and E.W. Davie, Nucleotide sequence of the gene for the b subunit of human factor XIII. Biochemistry, 1990. 29(51): p. 11195-209.
23. Webb, G.C., et al., Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus. Hum Genet, 1989. 81(2): p. 157-60.
24. Souri, M., H. Kaetsu, and A. Ichinose, Sushi domains in the B subunit of factor XIII responsible for oligomer assembly. Biochemistry, 2008. 47(33): p. 8656-64.
25. Greenberg, C.S., et al., Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. J Clin Invest, 1985. 75(5): p. 1463-70.
26. Moaddel, M., et al., Interactions of human fibrinogens with factor XIII: roles of calcium and the γ’ peptide. Biochemistry, 2000. 39(22): p. 6698-705.
27. Mosesson, M.W., Fibrinogen γ chain functions. J Thromb Haemost, 2003. 1(2): p. 231-8.
28. Siebenlist, K.R., D.A. Meh, and M.W. Mosesson, Plasma factor XIII binds specifically to fibrinogen molecules containing γ’ chains. Biochemistry, 1996. 35(32): p. 10448-53.
29. Souri, M., T. Osaki, and A. Ichinose, The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking. J Biol Chem, 2015. 290(19): p. 12027-39.
30. Anwar, R., et al., Identification of a new Leu354Pro mutation responsible for factor XIII deficiency. Eur J Haematol, 2001. 66(2): p. 133-6.
31. Gomez Garcia, E.B., et al., Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiency. Br J Haematol, 2001. 112(2): p. 513-8.
32. Koseki, S., et al., Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation. Blood, 2001. 97(9): p. 2667-72.
33. Biswas, A., et al., Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms. Hamostaseologie, 2014. 34(2): p. 160-6.
34. Biswas, A., et al., In vitro secretion deficits are common among human coagulation factor XIII subunit B missense mutants: correlations with patient phenotypes and molecular models. Hum Mutat, 2013. 34(11): p. 1490-500.
35. Thomas, A., et al., Structural and functional influences of coagulation factor XIII subunit B heterozygous missense mutants. Mol Genet Genomic Med, 2015. 3(4): p. 258-71.
36. National Center for Biotechnology Information. Variation Viewer: F13A1 gene-NM_000129.3. 2018 [cited 2018 2018, November 25th]; Available from: https://http://www.ncbi.nlm.nih.gov/variation/view/?q=2162%5Bgeneid%5D&assm=GCF_000001405.25.
37. Attie-Castro, F.A., et al., Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost, 2000. 84(4): p. 601-3.
38. McCormack, L.J., et al., Prevalence of FXIII V34L in populations with different cardiovascular risk. Thromb Haemost, 1998. 80(3): p. 523-4.
39. Kohler, H.P., et al., A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost, 1998. 80(4): p. 704.
40. Reiner, A.P., et al., Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women. Stroke, 2001. 32(11): p. 2580-6.
41. Anwar, R., et al., Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood, 1999. 93(3): p. 897-905.
42. Kohler, H.P., et al., Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost, 1998. 79(1): p. 8-13.
43. Wartiovaara, U., et al., Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost, 2000. 84(4): p. 595-600.
44. Hancer, V.S., et al., The association between factor XIII Val34Leu polymorphism and early myocardial infarction. Circ J, 2006. 70(3): p. 239-42.
45. Aleksic, N., et al., Factor XIIIA Val34Leu polymorphism does not predict risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol, 2002. 22(2): p. 348-52.
46. Warner, D., M.W. Mansfield, and P.J. Grant, Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography. Thromb Haemost, 2001. 85(3): p. 408-11.
47. Voko, Z., et al., Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis. Thromb Haemost, 2007. 97(3): p. 458-63.
48. Wells, P.S., et al., Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol, 2006. 164(2): p. 101-9.
49. Biswas, A., et al., Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function. Ann Hematol, 2014. 93(10): p. 1665-76.
50. Ivaškevičius, V., et al., Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A2. Haemophilia, 2017. 23(3): p. e194-e203.
51. Thomas, A., et al., Coagulation Factor XIIIA Subunit Missense Mutations Affect Structure and Function at the Various Steps of Factor XIII Action. Hum Mutat, 2016. 37(10): p. 1030-41.
52. Ivaškevičius, V., et al., International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost, 2007. 97(6): p. 914-21.
53. Seitz, R., et al., ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group. Semin Thromb Hemost, 1996. 22(5): p. 415-8.
54. Tosetto, A., G. Castaman, and F. Rodeghiero, Acquired plasma factor XIII deficiencies. Haematologica, 1993. 78(6 Suppl 2): p. 5-10.
55. Inbal, A. and R. Dardik, Role of coagulation factor XIII (FXIII) in angiogenesis and tissue repair. Pathophysiol Haemost Thromb, 2006. 35(1-2): p. 162-5.
56. Asahina, T., et al., Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv, 2007. 62(4): p. 255-60.
57. Oertel, K., et al., A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma. Anal Biochem, 2007. 367(2): p. 152-8.
58. Parameswaran, K.N., et al., Hydrolysis of γ:ε isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa. J Biol Chem, 1997. 272(15): p. 10311-7.
59. Roberts, H.R. and M.D. Bingham, Other coagulation factor deficiencies, in Thrombosis and Hemorrhage, J. Loscalzo and A.I. Schafer, Editors. 2003, Lippincott Williams and Wilkins: Philadelphia, PA. p. 592-593.
60. Lovejoy, A.E., et al., Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood, 2006. 108(1): p. 57-62.
61. Carcao, M., et al., Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency. Thromb Haemost, 2018. 118(3): p. 451-460.
62. Nugent, D.J., Prophylaxis in rare coagulation disorders — factor XIII deficiency. Thromb Res, 2006. 118 Suppl 1: p. S23-8.
63. Ichinose, A., T. Asahina, and T. Kobayashi, Congenital blood coagulation factor XIII deficiency and perinatal management. Curr Drug Targets, 2005. 6(5): p. 541-9.
Rare Coagulation Disorders Resource Room, an extension of the RBDD Registry (eu.rbdd.org), was developed in collaboration with the Indiana Hemophilia & Thrombosis Center (www.innovativehematology.org).
The Resource Room serves as a platform to promote international collaboration to increase knowledge of these very rare disorders and to improve the care of affected individuals. The international RBDD mission, under the leadership of Dr. Peyvandi, will continue to be expanded over time.
The Resource Room thanks all contributing authors of the website articles that have made this valuable information available to the global community of both individuals affected with rare coagulation disorders and their healthcare providers.
